Mohammed Eslam

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study

Eduardo Vilar‐Gómez, Luis Calzadilla Bertot, Vincent Wai‐Sun Wong et al. · Gastroenterology · 2018 · 792 citations · Full text

Medicine, Internal Medicine, Pathology +17

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

Sakura Yamamura, Mohammed Eslam, Takumi Kawaguchi et al. · Liver International · 2020 · 409 citations · Full text

Medicine, Internal Medicine, Pathology +17

Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation

Fei Chen, Saeed Esmaili, Geraint B. Rogers et al. · Hepatology · 2019 · 322 citations · Full text

Life Sciences, Biochemistry, Clinical Nutrition +16

ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

Samuel J. Daniels, Diana Julie Leeming, Mohammed Eslam et al. · Hepatology · 2018 · 257 citations · Full text

Medicine, Clinical Sciences, Pathology +17

Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

Ramy Younes, Olivier Govaere, Salvatore Petta et al. · Gut · 2021 · 202 citations · Full text

Medicine, Internal Medicine, Pathology +13